This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 January 2026.
All research outputs
#21,125,910
of 33,187,958 outputs
Outputs from International Journal of Drug Policy
#2,951
of 3,706 outputs
Outputs of similar age
#125,354
of 367,062 outputs
Outputs of similar age from International Journal of Drug Policy
#47
of 66 outputs
Altmetric has tracked 33,187,958 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,706 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,062 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
